Navigation Links
Chemring Detection Systems Awarded $500k for Strategic Research and Development
Date:2/27/2012

CHARLOTTE, N.C., Feb. 27, 2012 /PRNewswire/ -- Chemring Detection Systems (CDS) (http://www.chemringds.com), a Chemring Group PLC ("Chemring") subsidiary, is pleased to announce that it was awarded two strategic contracts for chemical detection.  The awards were made by the Joint Project Manager for Nuclear Biological and Chemical Contamination Avoidance (JPM NBC CA) for the Multi Mission Multi Threat Detection (M3TD) project.  "These important contracts help us to evaluate the capability of our new detection products," said Bill Gural, President of CDS.

The first award was in the "Raman" category for test and evaluation of the THOR-1064 product currently in development at CDS.  The THOR-1064 detects the presence of compounds in solid or liquid form, identifies the specific compound detected, and automatically alarms to notify users of a positive detection. THOR-1064 provides laboratory quality measurements in a rugged, handheld device.   The second award was in the Ion Mobility Spectrometry (IMS) category for test and evaluation of the Differential Mobility Spectrometer Vapor Detection System (DMSVD), a developmental prototype at CDS.  The DMSVD is a non-contact vapor detector based on Differential Mobility Spectrometry.  DMS offers improved sensitivity and selectivity over Ion Mobility Spectrometry based devices.  DMS technology has been implemented into CDS' JUNO® handheld vapor detector, currently available for sale, which includes a library of Toxic Industrial Chemicals (TICs) and chemical warfare agents.  Development work will be performed at Chemring Detection Systems' plant in Charlotte, NC and testing will be performed at Aberdeen Proving Ground and in Columbus, OH.

Notes to Editors:

  • Chemring Detection Systems is a business unit within Chemring Group PLC.
  • Chemring Group PLC is a market leading manufacturing business supplying high technology electronics and energetic products to over 80 countries around the world.
  • Chemring Group PLC has a diverse portfolio of products that predominantly protect military people and platforms, providing insurance against a constantly changing threat. These range from countermeasures to protect aircraft, to ground penetrating radar to protect troops and vehicles from improvised explosive devices.
  • Chemring Group PLC operates in niche markets with short product development timescales.  With strong barriers to entry the business has the agility to rapidly adapt to the urgent needs of our customers. The highly fragmented nature of many of its markets gives Chemring excellent opportunities to win further market share through manufacturing efficiencies and targeted acquisitions.
  • Chemring Group PLC's balanced geographic profile and diverse global markets positions it well to withstand economic downturn in any of its major markets. This gives confidence to be able to successfully navigate current defence cuts experienced in the US and Europe. Chemring continues to grow its presence in the Middle East and Asia and expects non-NATO revenues to reach 40% of the Group over the next two to three years. 
 

 


'/>"/>
SOURCE Chemring Detection Systems
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Forensic research extends detection of cyanide poisoning
2. Boulder Diagnostics Licenses Novel Rapid Detection Technology for Homocysteine and Related Compounds from Portland State University
3. Notre Dame researchers demonstrate new DNA detection technique
4. Sheffield scientists shine a light on the detection of bacterial infection
5. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
6. VisionGate Closes $2 Million Financing and Announces Collaboration to Evaluate Its 3D Cell Imaging Platform for Early Lung Cancer Detection
7. Sheffield scientists shine a light on the detection of bacterial infection
8. Cancer detection from an implantable, flexible LED
9. Nanowire-based sensors offer improved detection of volatile organic compounds
10. Molecular Detection Inc. and Eldan Electronic Instruments Announce Distribution Agreement for Detect-Ready® MRSA Panel in Israel
11. Regal One Announces Dividend of Rampart Detection Systems Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ... hosting a Webinar titled, “Pathology is going digital. Is your lab ready?” with ... adoption best practices and how Proscia improves lab economics and realizes an increase ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... Disappearing forests ... the lives of over 5.5 million people each year. Especially those living in larger ... startup Treepex - based in one of the most pollution-affected countries globally - decided ...
(Date:10/10/2017)... ... October 10, 2017 , ... San Diego-based team building and cooking ... initiative announced today. The bold new look is part of a transformation to ... into a significant growth period. , It will also expand its service offering from ...
(Date:10/10/2017)... , ... October 10, 2017 , ... Dr. Bob Harman, ... his local San Diego Rotary Club. The event entitled “Stem Cells ... and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human ...
Breaking Biology Technology:
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
Breaking Biology News(10 mins):